2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Nov 26, 2025.
-28.1% median (-28.1% mean) 90-day return after 2 previous buys.
The trade is 8.6% of the 148,479 shares held after it.
1 other insider bought within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Senior Vice President & CFO Lakhia Brad S. bought about $331.8K of CBZ on Mar 13, 2026, the largest insider purchase at the company on our record; 1 other insider bought within 30 days and 149 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 8, 2025.
-10.1% median (-10.1% mean) 90-day return after 3 previous buys.
The trade is 10.7% of the 9,310 shares held after it.
1 other insider bought within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director YOUNG RODNEY A bought about $26.1K of CBZ on Mar 13, 2026; 1 other insider bought within 30 days and 149 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Dec 2, 2025.
The trade is 99.8% of the 18,000 shares held after it.
No other insider sold within 30 days.
149 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WILEY BENAREE PRATT sold about $473.9K of CBZ on Mar 10, 2026, the largest insider sale at the company since 2024; 149 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CBZ planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CBZ mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
FAM SMALL CAP FUND
$17.5M position · as of 2026-06-30
5.6%
Fidelity Small Cap Stock Fund
$39.6M position · as of 2026-07-31
2.9%
Fidelity Small Cap Stock K6 Fund
$563.2K position · as of 2026-07-31
2.7%
Royce SMid-Cap Total Return Fund
$600.6K position · as of 2026-06-30
1.8%
Royce Small-Cap Total Return Fund
$15.6M position · as of 2026-06-30
1.6%
Taylor Frigon Core Growth Fund
$415.6K position · as of 2026-05-31
1.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Grisko
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$7.1M
$2.0M
$2.4M
+90%
+6%
2024
$5.4M
$9.9M
$2.3M
+208%
+26%
2023
$5.2M
$9.1M
$2.1M
+135%
+10%
2022
$4.9M
$9.8M
$2.0M
+76%
-2%
2021
$5.1M
$9.6M
$2.1M
+47%
+21%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 149 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CBZ
FY Dec 2025
$2.8B
FY Dec 2024
$1.8B
FY Dec 2023
$1.6B
FY Dec 2022
$1.4B
FY Dec 2021
$1.1B
Jun 2026
$682.2M
Mar 2026
n/a
Dec 2025
$542.7M
Sep 2025
$693.8M
Jun 2025
$683.5M
Mar 2025
$838.0M
Dec 2024
$460.3M
Sep 2024
$438.9M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CBZ
FY Dec 2025
+4.2%
FY Dec 2024
+2.3%
FY Dec 2023
+7.6%
FY Dec 2022
+7.5%
FY Dec 2021
+6.4%
Jun 2026
+2.7%
Mar 2026
n/a
Dec 2025
-14.6%
Sep 2025
+4.3%
Jun 2025
+6.1%
Mar 2025
+14.7%
Dec 2024
-19.7%
Sep 2024
+8.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$272.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CBZ
FY Dec 2025
$175.5M
FY Dec 2024
$110.8M
FY Dec 2023
$130.5M
FY Dec 2022
$117.5M
FY Dec 2021
$122.2M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
$141.7M
Sep 2025
$22.1M
Jun 2025
$105.2M
Mar 2025
-$93.4M
Dec 2024
$52.3M
Sep 2024
$41.1M
At each fiscal year end
Single quarter
Debt to equity
0.78x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CBZ
FY Dec 2025
0.83x
FY Dec 2024
0.79x
FY Dec 2023
0.39x
FY Dec 2022
0.37x
FY Dec 2021
0.22x
Jun 2026
0.78x
Mar 2026
0.77x
Dec 2025
0.83x
Sep 2025
0.84x
Jun 2025
0.82x
Mar 2025
0.80x
Dec 2024
0.79x
Sep 2024
0.36x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.20x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CBZ
FY Dec 2025
0.13x
FY Dec 2024
0.09x
FY Dec 2023
0.49x
FY Dec 2022
0.48x
FY Dec 2021
0.85x
Jun 2026
0.20x
Mar 2026
0.18x
Dec 2025
0.13x
Sep 2025
0.07x
Jun 2025
0.08x
Mar 2025
0.06x
Dec 2024
0.09x
Sep 2024
0.49x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+6.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CBZ
FY Dec 2025
+6.5%
FY Dec 2024
+3.2%
FY Dec 2023
+16.1%
FY Dec 2022
+14.9%
FY Dec 2021
+10.1%
Jun 2026
+6.5%
Mar 2026
+7.7%
Dec 2025
+6.5%
Sep 2025
+7.4%
Jun 2025
+7.8%
Mar 2025
+6.2%
Dec 2024
+3.2%
Sep 2024
+13.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CBZ
FY Dec 2025
+2.6%
FY Dec 2024
+1.3%
FY Dec 2023
+6.2%
FY Dec 2022
+6.0%
FY Dec 2021
+4.5%
Jun 2026
+2.7%
Mar 2026
+3.3%
Dec 2025
+2.6%
Sep 2025
+3.1%
Jun 2025
+3.3%
Mar 2025
+2.6%
Dec 2024
+1.3%
Sep 2024
+5.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CBZ
FY Dec 2025
+5.2%
FY Dec 2024
+2.0%
FY Dec 2023
+11.4%
FY Dec 2022
+12.9%
FY Dec 2021
+6.5%
Jun 2026
n/a
Mar 2026
+5.0%
Dec 2025
+5.2%
Sep 2025
+5.1%
Jun 2025
+4.9%
Mar 2025
+4.1%
Dec 2024
+2.0%
Sep 2024
+9.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CBZ
FY Dec 2025
+6.3%
FY Dec 2024
+2.8%
FY Dec 2023
+11.4%
FY Dec 2022
+13.1%
FY Dec 2021
+6.2%
Jun 2026
n/a
Mar 2026
+6.2%
Dec 2025
+6.3%
Sep 2025
+7.6%
Jun 2025
+7.2%
Mar 2025
+6.2%
Dec 2024
+2.8%
Sep 2024
+9.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
26.74x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CBZ
FY Dec 2025
27.72x
FY Dec 2024
104.91x
FY Dec 2023
26.19x
FY Dec 2022
23.19x
FY Dec 2021
29.86x
Jun 2026
15.65x
Mar 2026
11.19x
Dec 2025
27.72x
Sep 2025
43.77x
Jun 2025
50.15x
Mar 2025
65.40x
Dec 2024
104.91x
Sep 2024
28.39x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$4.4B
market value at close 2026-10-27 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CBZ
FY Dec 2025
$4.2B
FY Dec 2024
$5.5B
FY Dec 2023
$3.4B
FY Dec 2022
$2.6B
FY Dec 2021
$2.2B
Jun 2026
$3.2B
Mar 2026
$2.9B
Dec 2025
$4.2B
Sep 2025
$4.4B
Jun 2025
$5.4B
Mar 2025
$5.6B
Dec 2024
$5.5B
Sep 2024
$3.7B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.2%
TTM free cash flow over market value at close 2026-10-27
FCF yield CBZ
FY Dec 2025
+6.4%
FY Dec 2024
+2.7%
FY Dec 2023
+4.2%
FY Dec 2022
+4.9%
FY Dec 2021
+6.0%
Jun 2026
+15.4%
Mar 2026
+16.1%
Dec 2025
+6.4%
Sep 2025
+3.0%
Jun 2025
+2.7%
Mar 2025
+2.1%
Dec 2024
+2.7%
Sep 2024
+4.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.62x
P/E over trailing EPS growth of 43%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CBZ
FY Dec 2025
0.21x
FY Dec 2024
n/a
FY Dec 2023
1.43x
FY Dec 2022
0.43x
FY Dec 2021
n/a
Jun 2026
0.36x
Mar 2026
0.10x
Dec 2025
0.21x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CBZ ranks highest on growth (89th percentile) and profitability (54th), and lowest on risk and compliance (24th), among Services peers.
Profitability
54
Inputs
Return on equity+6.5% · 50 pct, sector of 207
Return on assets+2.7% · 58 pct, sector of 269
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
41
Inputs
Debt to equity0.78x · 34 pct, sector of 228
Cash flow to debt0.20x · 47 pct, sector of 199
Growth
89
Inputs
Revenue growth, YoY+52.1% · 89 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
37
Inputs
Funds adding, latest quarter149 · 62 pct, sector of 243
Congress net buyers, 365d-1 · 11 pct, sector of 37
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
24
Inputs
Short interest, % of float+4.3% · 39 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+29.6% · 8 pct, sector of 227
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CBZ filings, in plain words
Have members of Congress traded CBZ?
Yes. In the year to 2026-10-28, 1 House member disclosed buying CBZ and 2 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-06-30.
Read the full summary
In the year to 2026-10-28, 1 member of Congress disclosed buying CBZ and 2 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-06-30. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.